BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rutigliano G, Accorroni A, Zucchi R. The Case for TAAR1 as a Modulator of Central Nervous System Function. Front Pharmacol 2017;8:987. [PMID: 29375386 DOI: 10.3389/fphar.2017.00987] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Liao S, Pino MJ Jr, Deleon C, Lindner-Jackson M, Wu C. Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB. Life Sci 2022;:120553. [PMID: 35452636 DOI: 10.1016/j.lfs.2022.120553] [Reference Citation Analysis]
2 Gillman PK. A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths. J Neural Transm (Vienna) 2018;125:1707-17. [PMID: 30255284 DOI: 10.1007/s00702-018-1932-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
3 Wu R, Liu J, Seaman R Jr, Johnson B, Zhang Y, Li JX. The selective TAAR1 partial agonist RO5263397 promoted novelty recognition memory in mice. Psychopharmacology (Berl) 2021. [PMID: 34291306 DOI: 10.1007/s00213-021-05937-1] [Reference Citation Analysis]
4 Spangler JR, Caruana JC, Medintz IL, Walper SA. Harnessing the potential of Lactobacillus species for therapeutic delivery at the lumenal-mucosal interface. Future Sci OA 2021;7:FSO671. [PMID: 33815818 DOI: 10.2144/fsoa-2020-0153] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zucchi R, Rutigliano G, Saponaro F. Novel thyroid hormones. Endocrine 2019;66:95-104. [DOI: 10.1007/s12020-019-02018-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
6 Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L. Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia. ACS Med Chem Lett 2022;13:92-8. [PMID: 35047111 DOI: 10.1021/acsmedchemlett.1c00527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Dorotenko A, Tur M, Dolgorukova A, Bortnikov N, Belozertseva IV, Zvartau EE, Gainetdinov RR, Sukhanov I. The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats. Cell Mol Neurobiol 2020;40:215-28. [PMID: 31734895 DOI: 10.1007/s10571-019-00757-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 de Oliveira Pacheco C, de Gomes MG, da Silva Neto MR, Parisotto AJM, Dos Santos RB, Maciel TR, Ribeiro ACF, Giacomeli R, Haas SE. Surface-functionalized curcumin-loaded polymeric nanocapsules could block apomorphine-induced behavioral changes in rats. Pharmacol Rep 2021. [PMID: 34739705 DOI: 10.1007/s43440-021-00331-2] [Reference Citation Analysis]
9 Zhukov DA, Vinogradova EP. Trace Amines and Behavior. Neurochem J 2020;14:347-52. [DOI: 10.1134/s1819712420040108] [Reference Citation Analysis]
10 Dedic N, Jones PG, Hopkins SC, Lew R, Shao L, Campbell JE, Spear KL, Large TH, Campbell UC, Hanania T, Leahy E, Koblan KS. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D 2 Receptor Mechanism of Action. J Pharmacol Exp Ther 2019;371:1-14. [DOI: 10.1124/jpet.119.260281] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
11 Kostrzewa RM, Wydra K, Filip M, Crawford CA, McDougall SA, Brown RW, Borroto-Escuela DO, Fuxe K, Gainetdinov RR. Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders. J Pharmacol Exp Ther 2018;366:519-26. [PMID: 29921706 DOI: 10.1124/jpet.118.247981] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
12 Liu J, Wu R, Seaman R, Manz KM, Johnson B, Vu J, Huang Y, Zhang Y, Robison AJ, Neve R, Grueter BA, Dietz D, Li J. TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKIIα activity in the NAc. Mol Psychiatry. [DOI: 10.1038/s41380-022-01448-3] [Reference Citation Analysis]
13 Biebermann H, Kleinau G. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors. Exp Clin Endocrinol Diabetes 2020;128:395-400. [PMID: 31698479 DOI: 10.1055/a-1022-1554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Xu Z, Li Q. TAAR Agonists. Cell Mol Neurobiol 2020;40:257-72. [PMID: 31848873 DOI: 10.1007/s10571-019-00774-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Liu J, Johnson B, Wu R, Seaman R Jr, Vu J, Zhu Q, Zhang Y, Li JX. TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking. Br J Pharmacol 2020;177:3403-14. [PMID: 32246467 DOI: 10.1111/bph.15061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Nakamura Y, Arawaka S, Sato H, Sasaki A, Shigekiyo T, Takahata K, Tsunekawa H, Kato T. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion In Vitro and Delays Its Aggregation in rAAV-Based Rat Models of Parkinson's Disease. J Neurosci 2021;41:7479-91. [PMID: 34290084 DOI: 10.1523/JNEUROSCI.0476-21.2021] [Reference Citation Analysis]
17 Borsò M, Agretti P, Zucchi R, Saba A. Mass spectrometry in the diagnosis of thyroid disease and in the study of thyroid hormone metabolism. Mass Spectrom Rev 2020. [PMID: 33238065 DOI: 10.1002/mas.21673] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Laurino A, Landucci E, Raimondi L. Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases. Front Endocrinol (Lausanne) 2018;9:290. [PMID: 29928258 DOI: 10.3389/fendo.2018.00290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zucchi R. Thyroid Hormone Analogues: An Update. Thyroid 2020;30:1099-105. [PMID: 32098589 DOI: 10.1089/thy.2020.0071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
20 Zhang Y, Li JT, Wang H, Niu WP, Zhang CC, Zhang Y, Wang XD, Si TM, Su YA. Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice. Pharmacol Res 2021;167:105571. [PMID: 33753244 DOI: 10.1016/j.phrs.2021.105571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Köhrle J, Biebermann H. 3-Iodothyronamine—A Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action. Endocrine Reviews 2019;40:602-30. [DOI: 10.1210/er.2018-00182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
22 Eslami-Amirabadi M, Sajjadi SA. The relation between thyroid dysregulation and impaired cognition/behaviour: An integrative review. J Neuroendocrinol 2021;33:e12948. [PMID: 33655583 DOI: 10.1111/jne.12948] [Reference Citation Analysis]
23 Alnefeesi Y, Tamura JK, Lui LMW, Jawad MY, Ceban F, Ling S, Nasri F, Rosenblat JD, McIntyre RS. Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review. Neurosci Biobehav Rev 2021;131:192-210. [PMID: 34537265 DOI: 10.1016/j.neubiorev.2021.09.020] [Reference Citation Analysis]
24 Koch J, Shi WX, Dashtipour K. VMAT2 inhibitors for the treatment of hyperkinetic movement disorders. Pharmacol Ther 2020;212:107580. [PMID: 32454050 DOI: 10.1016/j.pharmthera.2020.107580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Pretorius L, Smith C. The trace aminergic system: a gender-sensitive therapeutic target for IBS? J Biomed Sci 2020;27:95. [PMID: 32981524 DOI: 10.1186/s12929-020-00688-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Schützler N, Girwert C, Hügli I, Mohana G, Roignant JY, Ryglewski S, Duch C. Tyramine action on motoneuron excitability and adaptable tyramine/octopamine ratios adjust Drosophila locomotion to nutritional state. Proc Natl Acad Sci U S A 2019;116:3805-10. [PMID: 30808766 DOI: 10.1073/pnas.1813554116] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
27 Zoubková H, Tomášková A, Nohejlová K, Černá M, Šlamberová R. Prenatal Exposure to Methamphetamine: Up-Regulation of Brain Receptor Genes. Front Neurosci 2019;13:771. [PMID: 31417344 DOI: 10.3389/fnins.2019.00771] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
28 Calvey T. Human Self-Domestication and the Extended Evolutionary Synthesis of Addiction: How Humans Evolved a Unique Vulnerability. Neuroscience 2019;419:100-7. [PMID: 31654715 DOI: 10.1016/j.neuroscience.2019.09.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
29 Stafford AM, Reed C, Baba H, Walter NA, Mootz JR, Williams RW, Neve KA, Fedorov LM, Janowsky AJ, Phillips TJ. Taar1 gene variants have a causal role in methamphetamine intake and response and interact with Oprm1. Elife 2019;8:e46472. [PMID: 31274109 DOI: 10.7554/eLife.46472] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
30 Cisneros IE, Ghorpade A, Borgmann K. Methamphetamine Activates Trace Amine Associated Receptor 1 to Regulate Astrocyte Excitatory Amino Acid Transporter-2 via Differential CREB Phosphorylation During HIV-Associated Neurocognitive Disorders. Front Neurol 2020;11:593146. [PMID: 33324330 DOI: 10.3389/fneur.2020.593146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Stohs SJ, Shara M, Ray SD. p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties. Phytother Res 2020;34:1838-46. [PMID: 32101364 DOI: 10.1002/ptr.6649] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
32 Rutigliano G, Zucchi R. Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders. Cell Mol Neurobiol 2020;40:239-55. [PMID: 31643000 DOI: 10.1007/s10571-019-00743-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
33 Bortolato M, Floris G, Shih JC. From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency. J Neural Transm (Vienna) 2018;125:1589-99. [PMID: 29748850 DOI: 10.1007/s00702-018-1888-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
34 Francesconi V, Cichero E, Kanov EV, Laurini E, Pricl S, Gainetdinov RR, Tonelli M. Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Pharmaceuticals (Basel) 2020;13:E391. [PMID: 33202687 DOI: 10.3390/ph13110391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
35 Rutigliano G, Bräunig J, Del Grande C, Carnicelli V, Masci I, Merlino S, Kleinau G, Tessieri L, Pardossi S, Paisdzior S, Dell'Osso L, Biebermann H, Zucchi R. Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders. Front Pharmacol 2019;10:1027. [PMID: 31572197 DOI: 10.3389/fphar.2019.01027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
36 Rutigliano G, Bandini L, Sestito S, Chiellini G. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome? Int J Mol Sci 2020;21:E2005. [PMID: 32183490 DOI: 10.3390/ijms21062005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
37 Mantas I, Millan MJ, Di Cara B, Groenink L, Veiga S, Cistarelli L, Brocco M, Bertrand M, Svenningsson P, Zhang X. Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based Antidepressants. Int J Mol Sci 2021;22:8907. [PMID: 34445611 DOI: 10.3390/ijms22168907] [Reference Citation Analysis]
38 Freyberg Z, Saavedra JM. Trace Amines and Trace Amine-Associated Receptors: A New Frontier in Cell Signaling. Cell Mol Neurobiol 2020;40:189-90. [PMID: 32006222 DOI: 10.1007/s10571-020-00800-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Kozlowska U, Nichols C, Wiatr K, Figiel M. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders. J Neurochem 2021. [PMID: 34519052 DOI: 10.1111/jnc.15509] [Reference Citation Analysis]
40 Farfán-García ED, Márquez-Gómez R, Barrón-González M, Pérez-Capistran T, Rosales-Hernández MC, Pinto-Almazán R, Soriano-Ursúa MA. Monoamines and their Derivatives on GPCRs: Potential Therapy for Alzheimer's Disease. Curr Alzheimer Res 2019;16:871-94. [PMID: 30963972 DOI: 10.2174/1570159X17666190409144558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Mantas I, Vallianatou T, Yang Y, Shariatgorji M, Kalomoiri M, Fridjonsdottir E, Millan MJ, Zhang X, Andrén PE, Svenningsson P. TAAR1-Dependent and -Independent Actions of Tyramine in Interaction With Glutamate Underlie Central Effects of Monoamine Oxidase Inhibition. Biol Psychiatry 2021;90:16-27. [PMID: 33579534 DOI: 10.1016/j.biopsych.2020.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Wu R, Li JX. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders. CNS Drugs 2021;35:1239-48. [PMID: 34766253 DOI: 10.1007/s40263-021-00871-4] [Reference Citation Analysis]
43 Kantrowitz JT. Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions. CNS Drugs 2021;35:1153-61. [PMID: 34655036 DOI: 10.1007/s40263-021-00864-3] [Reference Citation Analysis]
44 Galluppi GR, Polhamus DG, Fisher JM, Hopkins SC, Koblan KS. Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia. CPT Pharmacometrics Syst Pharmacol 2021. [PMID: 34292664 DOI: 10.1002/psp4.12692] [Reference Citation Analysis]
45 Accorroni A, Rutigliano G, Sabatini M, Frascarelli S, Borsò M, Novelli E, Bandini L, Ghelardoni S, Saba A, Zucchi R, Origlia N. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity. Thyroid 2020;30:147-60. [PMID: 31709926 DOI: 10.1089/thy.2019.0255] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
46 Hopkins SC, Dedic N, Koblan KS. Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans. Transl Psychiatry 2021;11:228. [PMID: 33879769 DOI: 10.1038/s41398-021-01331-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Tonelli M, Cichero E. Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present). Expert Opinion on Therapeutic Patents 2020;30:137-45. [DOI: 10.1080/13543776.2020.1708900] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
48 Fan FS. Ractopamine residue in meat might protect people from Parkinson disease. Med Hypotheses 2020;145:110397. [PMID: 33223323 DOI: 10.1016/j.mehy.2020.110397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Dodd S, F Carvalho A, Puri BK, Maes M, Bortolasci CC, Morris G, Berk M. Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry? Neurosci Biobehav Rev 2021;120:537-41. [PMID: 33031817 DOI: 10.1016/j.neubiorev.2020.09.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]